Evidence map›Paper›PMID 21628527›Full record

ArticleMolecular and cellular biology2011

Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex.

Etsuko Shibata, Tarek Abbas, Xinhua Huang, James A Wohlschlegel, Anindya Dutta

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in molecular biosciences · 2023
    Article
  4. Article
  5. Article
  6. Increased UBE2L6 regulated by type 1 interferon as potential marker in TB.Journal of cellular and molecular medicine · 2021
    Article
  7. Mitochondrial DNA: cellular genotoxic stress sentinel.Trends in biochemical sciences · 2021
    Review
  8. Article
  9. Article
  10. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.Journal of experimental & clinical cancer research : CR · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Etsuko ShibataDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia 22908, USA.
Tarek Abbas
Xinhua Huang
James A Wohlschlegel
Anindya Dutta
University of Virginia · USUniversity of California, Los Angeles · US

Funding

Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
The role of MCM8-9 in genomic instability of cancersR01CA060499 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Anindya Dutta · 1994 to 2026
$8.6M
Proteolytic Control of Iron Metabolism by the Ubiquitin Ligase FBXL5R01GM089778 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOHLSCHLEGEL, JAMES AKIRA · 2010 to 2023
$4.0M
ROLE OF CY MOTIFS IN SUBSTRATE RECOGNITION BY CDKSR01CA089406 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI DUTTA, ANINDYA · 2001 to 2011
$2.1M
The Role of CRL4-Cdt2 E3 Ubiquitin Ligase in Genomic Stability and CancerR00CA140774 · NCI · UNIVERSITY OF VIRGINIA · PI ABBAS, TAREK A. · 2012 to 2014
$725k
The Role of CRL4-Cdt2 E3 Ubiquitin Ligase in Genomic Stability and CancerK99CA140774 · NCI · UNIVERSITY OF VIRGINIA · PI ABBAS, TAREK A. · 2010 to 2011
$246k
NCI NIH HHS CA89406NCI NIH HHS K99 CA140774NCI NIH HHS R00 CA140774NCI NIH HHS R01 CA060499NCI NIH HHS R01 CA089406NCI NIH HHS R01 CA60499NCI NIH HHS T32 CA009109NCI NIH HHS T32CA009109NIGMS NIH HHS R01 GM089778PHS HHS KCA140774A
6 · The paper itself

Abstract

CRL4(Cdt2) is a cullin-based E3 ubiquitin ligase that promotes the ubiquitin-dependent proteolysis of various substrates implicated in the control of cell cycle and various DNA metabolic processes such as DNA replication and repair. Substrates for CRL4(Cdt2) E3 ubiquitin ligase include the replication licensing factor Cdt1 and the cyclin-dependent kinase (Cdk) inhibitor p21. Inhibition of this E3 ligase leads to serious abnormalities of the cell cycle and cell death. The ubiquitin-conjugating enzyme (UBC) involved in this important pathway, however, remains unknown. By a proteomic analysis of Cdt2-associated proteins and an RNA interference-based screening approach, we show that CRL4(Cdt2) utilizes two different UBCs to target different substrates. UBCH8, a member of the UBE2E family of UBCs, ubiquitylates and promotes the degradation of p21, both during the normal cell cycle and in UV-irradiated cells. Importantly, depletion of UBCH8 by small interfering RNA (siRNA) increases p21 protein level, delays entry into S phase of the cell cycle, and suppresses the DNA damage response after UV irradiation. On the other hand, members of the UBE2G family of UBCs (UBE2G1 and UBE2G2) cooperate with CRL4(Cdt2) to polyubiquitylate and degrade Cdt1 postradiation, an activity that is critical for preventing origin licensing in DNA-damaged cells. Finally, we show that UBCH8, but not UBE2G1 or UBE2G2, is required for CRL4(Cdt2)-mediated ubiquitylation and degradation of the histone H4 lysine 20 monomethyltransferase Set8, a previously identified CRL4(Cdt2) substrate, as well as for CRL4(Cdt2)-dependent monoubiquitylation of PCNA in unstressed cells. These findings identify the UBCs required for the activity of CRL4(Cdt2) on multiple substrates and demonstrate that different UBCs are involved in the selective ubiquitylation of different substrates by the same E3 complex.

Indexed as

Cell CycleCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA RepairHCT116 CellsHistonesHumansNuclear ProteinsPolymerase Chain ReactionProtein Processing, Post-TranslationalProteomicsRNA InterferenceRNA, Small InterferingUbiquitinationUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligase ComplexesCDT1 protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DTL protein, humanHistonesNuclear ProteinsRNA, Small InterferingUBE2G1 protein, humanUBE2L6 protein, humanUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligases

Identifiers

PMID21628527
PMCPMC3147600
OpenAlexW2120923391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.